{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:10:52Z","timestamp":1761059452226},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/jcp.0b013e318270e5e2","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T10:17:20Z","timestamp":1352197040000},"page":"832-834","source":"Crossref","is-referenced-by-count":12,"title":["Valproic Acid Treatment Is Associated With Altered Leukocyte Subset Development"],"prefix":"10.1097","volume":"32","author":[{"given":"Marije","family":"Bartels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter W.","family":"van Solinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke J.","family":"den Breeijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc B.","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Coffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toine C.G.","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylases inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia.","volume":"25","author":"Quintas-Cardama","year":"2011","journal-title":"Leukemia"},{"issue":"5","key":"R2-18-20210128","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies.","volume":"11","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"R3-18-20210128","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2005.16.600","article-title":"Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.","volume":"23","author":"Bhalla","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"R4-18-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","article-title":"Hematologic toxicity of sodium valproate.","volume":"22","author":"Acharya","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"R5-18-20210128","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","article-title":"Valproate induced thrombocytopenia; a prospective monotherapy study.","volume":"49","author":"Nasreddine","year":"2008","journal-title":"Epilepsia"},{"key":"R7-18-20210128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/adc.57.9.681","article-title":". Valproic acid and immune thrombocytopenia.","volume":"57","author":"Barr","year":"1982","journal-title":"Arch Dis Child"},{"issue":"6","key":"R8-18-20210128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1528-1157.1993.tb02139.x","article-title":"Hematological manifestations of long-term valproate therapy.","volume":"34","author":"May","year":"1993","journal-title":"Epilepsia"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood-2008-02-140806","article-title":". Lymphoid-affiliated genes are associated with active histone modifications in human hematopoietic stem cells.","volume":"112","author":"Maes","year":"2008","journal-title":"Blood"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":". Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.","volume":"115","author":"Van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"R17-18-20210128","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":". Deacetylase inhibition promotes the generation and function of regulatory T cells.","volume":"13","author":"Tao","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly; possible drug interactions and adverse effects.","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318270e5e2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:23Z","timestamp":1620957623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201212000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318270e5e2","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}